1)lipofectin脂质体法
1.Perfect cell transfection efficiency was acquired with the comparisons of three cell transfection assays(Electroporation, calcium phosphate method and lipofectin reagent) to carry out further studies on gene expression regulation and mouse ES cell targeting.通过对3种细胞转染方法(电穿孔法,磷酸钙法,阳离子性的脂质体法)的比较及优化,获得了理想的转染率,以进一步从细胞水平研究基因表达调控及小鼠ES细胞打靶。
2.The transfection efficiency of electroporation and lipofectin mediated methods was compared.实验对电穿孔法和阳离子脂质体法转染水牛胎儿成纤维细胞的条件进行了系统摸索,获得了较好的DNA转染参数。
2)liposome injection脂质体注入法
3)Smad3脂质体介导法
英文短句/例句
1.The Study of Technology Route of Transgenic Chicken Producing with Liposome-mediated Green Fluorescent Protein Gene;脂质体介导法转绿色荧光蛋白基因鸡的技术路线研究
2.Studies on Active Targeting Liposomes Directed by Chimeric TNT-3 Monoclonal Antibody;chTNT-3介导的主动靶向脂质体的研究
3.Study on Therapy for Asthma by Aerosolizing Delivery of CpGODN Mediated by a New Type Cationic Liposome;新型阳离子脂质体雾化介导CpGODN哮喘基因治疗方法的探讨
4.Studies on the Factors Influencing Establishment of Cell Line Porcine Embryonic Fibroblasts and Cationic Liposome Mediated Transfection;猪胎儿成纤维细胞建系影响因素与脂质体介导转染法的研究
5.Liposome-Mediated Exogenous DNA Uptake by Goat Sperm Cells脂质体介导外源基因体外转染山羊精子的研究
6.Studies on hALR Transfecting Sheep Embryonic Fibroblasts Cell Mediated by Liposome;脂质体介导hALR转染绵羊胎儿成纤维细胞的研究
7.Transfection of Foreign DNA into Bone Marrow-Endothelial Progenitorcells (BM-EPCs) Mediated by Cationic Liposome阳离子脂质体介导的基因转染大鼠BM-EPC的研究
8.Comparison of two kinds of cationic vectors-mediated gene delivery两种阳离子脂质体介导基因转染的比较研究
9.Advances in Studies of Liposomal Vincristine长春新碱脂质体介导的肿瘤化疗研究现状
10.Influence of Liposome-mediated and Naked Plasmid DNA Methods on Expression of CYP2J3 Gene in Rat Smooth Muscle Cells裸质粒与脂质体介导转染方法对大鼠平滑肌细胞CYP2J3基因表达的影响
11.The Study on Establishing Transgenic Tupaias and Mouse with HBx, Kras Gene by Spermatozoa-mediated Gene Transfer脂质体介导精子载体法建立转HBx、突变Kras基因树鼩和小鼠动物模型的研究
12.Effects of Lipofectemine Mediated bFGF-Math1 Gene Transfer to UEC-4 Cell on Reduction and Differentiation;脂质体介导的bFGF-Math1基因在UEC-4细胞中的表达及诱导分化作用
13.Chondrogenic Differentiation of Mesenchymal Stem Cells by Insulinlike Growth Factor-1 Gene Transfection with Liprofectamine;脂质体介导IGF-1基因修饰骨髓间充质干细胞成软骨分化
14.The Expression of Green Fluocescent Protein Gene Transfected the Bone Marrow Stromal Cells with Lipofectin;脂质体介导转染的绿色荧光蛋白基因在骨髓基质细胞内表达
15.Liposome-mediated Plasmid pEGFP-N1 Transfection of Mouse Spermatogenic Function脂质体介导质粒pEGFP-N1转染对小鼠睾丸生精功能的影响
16.Optimization of Transfection Conditions for Tranfecting pAcGFP-bFADD Recombinant Plasmid to Hela Cell Mediated by Lipofectamine 2000脂质体介导pAcGFP-bFADD重组质粒转染Hela细胞条件的优化
17.Protection of Intrahepatic Injection of Liposome-mediated VEGF Plasmid against Ischemia-reperfusion Liver Injury脂质体介导的VEGF质粒肝脏内注射对肝缺血再灌注损伤的保护作用
18.Transfection of mouse bone marrow mesenchymal stem cells with liposome mediated cytosine deaminase genes脂质体介导胞嘧啶脱氨酶基因转染鼠骨髓间充质干细胞
相关短句/例句
liposome injection脂质体注入法
3)Smad3脂质体介导法
4)galactosyl ceramide liposomes糖脂脂质体
5)Liposome immunoassay(LIA)脂质体-免疫分析法
6)LONG-CIRCULATING LIPOSOMES/methods长循环脂质体/方法
延伸阅读
多相脂质体139 , 三氨酸多相脂质体,油酸多相脂质体注射液药物名称：油酸多相脂质体注射液英文名：Polyphase Liposome-139别名： 139;多相脂质体139 , 三氨酸多相脂质体,油酸多相脂质体注射液外文名：Polyphase Liposome-139适应症： 用于治疗各种消化管癌（如胃癌、结肠癌、肝癌、胰腺癌、食管癌等）、肺癌、淋巴肉瘤、乳腺癌等。 用量用法： 开始时１日量２０ｍｌ，如无不良反应，逐渐增大剂量，最多可至１日５０ｍｌ，加入氯化钠注射液中（２５０～５００ｍｌ）混匀，缓缓静滴，滴速控制在每分钟４０～６０滴，每日１次，１个疗程总量１２００～１５００ｍｌ。如单用本品，１个疗程结束后，休息１周，进行复查，然后继续第２疗程。如是手术病人，术后２周开始维持给药，１日５０ｍｌ，每周２次，用１个月。本品亦可与化疗或放疗合用，先用本品１疗程，休息１周后，，再按常规使用化疗或放疗，可减轻化疗药物的毒副作用，提高机体免疫功能。 注意事项： 1.用前将注射液振摇均匀后与等渗盐水混匀。 2.偶有面部发热，仅需减慢滴速即能恢复正常。 3.禁用于直接静脉推注，以免危险。 4.开始用药２～３日内白细胞可能略有下降，继续给药随即回升至正常水平。 规格： 针剂：１０ｍｌ。 类别：其他抗肿瘤药及辅助治疗药
